Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX2OB3
|
||||
Drug Name |
(+/-)-2-(benzo[c][1,2,5]thiadiazole-4-sulfonamido)-4-chloro-N-(2-(3,4-dichlorophenyl)propyl)benzamide
|
||||
Synonyms |
CHEMBL583457
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C22H17Cl3N4O3S2
|
||||
Canonical SMILES |
CC(CNC(=O)c1ccc(Cl)cc1NS(=O)(=O)c2cccc3nsnc23)c4ccc(Cl)c(Cl)c4
|
||||
InChI |
InChI=1S/C22H17Cl3N4O3S2/c1-12(13-5-8-16(24)17(25)9-13)11-26-22(30)15-7-6-14(23)10-19(15)29-34(31,32)20-4-2-3-18-21(20)28-33-27-18/h2-10,12,29H,11H2,1H3,(H,26,30)
|
||||
InChIKey |
MBXSGYVYBZBMFK-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.